Embecta (Nasdaq:EMBC) announced today that it entered into a definitive agreement to acquire Owen Mumford Holdings Limited.

Embecta hits multi-year lows on GLP-1 fears, but offers 6%+ yield and deep value. Read the latest analysis on the stock and ...

Diabetes hardware company embecta aims to look beyond insulin and reshape itself into a more varied drug delivery provider—and it’s kick-starting that effort with the acquisition of a glo | Embecta ...

Shares are trading at a reported 4.1x forward earnings, offer a 5.2% dividend yield, and the stock is down more than 40% YTD, thus representing a fat discount to recent prices. Seems like a bargain at ...

Embecta Balances Near-Term Headwinds With Strategic Momentum in Latest Earnings Call Embecta Corporation’s latest earnings call painted a picture of a company managing through meaningful near-term ...